Dominique Stoppa-Lyonnet | Institut CurieFRA12 aut.14 aut. France Institut Curie Institut Curie
| 004D71
| Institut National de la Santé et de la Recherche Médicale, U830FRA14 aut. France U830 Institut National de la Santé et de la Recherche Médicale, U830
| 004D71
| GEMO study: Cancer Genetics Network “Groupe Génétique et Cancer”, Fédération Nationale des Centres de Lutte Contre le Cancer, France France GEMO study: Cancer Genetics Network “Groupe Génétique et Cancer”, Fédération Nationale des Centres de Lutte Contre le Cancer Fédération Nationale des Centres de Lutte Contre le Cancer Fédération Nationale des Centres de Lutte Contre le Cancer
| 005635
| GEMO Study Collaborators: Cancer Genetics Network “Groupe Génétique et Cancer”, Fédération Nationale des Centres de Lutte Contre le Cancer, France France GEMO Study Collaborators: Cancer Genetics Network “Groupe Génétique et Cancer”, Fédération Nationale des Centres de Lutte Contre le Cancer Fédération Nationale des Centres de Lutte Contre le Cancer Fédération Nationale des Centres de Lutte Contre le Cancer
| 005685
| Service de génétique oncologique, Institut Curie, Inserm U830, 26 rue d’Ulm, 75248 Paris, France France Service de génétique oncologique, Institut Curie, Inserm U830, 26 rue d’Ulm, 75248 Paris 75248 Paris ParisÎle-de-France
| 003172
| Service de Génétique Oncologique, Institut Curie, 26 rue d’Ulm, 75248 Paris Cedex 05, France France Service de Génétique Oncologique, Institut Curie, 26 rue d’Ulm, 75248 Paris Cedex 05 75248 Paris Cedex 05 75248 Paris Cedex 05
| 002327
| Service de Génétique Oncologique, Institut Curie, 26, rue d’Ulm, Paris, Cedex 05, France France Service de Génétique Oncologique, Institut Curie, 26, rue d’Ulm, Paris, Cedex 05 Cedex 05 Cedex 05
| 001C61
| 0000 0004 0639 6384grid.418596.7Department of Tumour Biology, Institut Curie,Paris, France France Paris
| 003C36
| 0000 0004 0639 6384grid.418596.7Institut Curie, INSERM U830,Paris, France France Paris
| 003C36
| Service de Génétique Oncologique, Institut Curie, 26 rue d'Ulm 75248 Paris cedex 05, France France Service de Génétique Oncologique, Institut Curie, 26 rue d'Ulm 75248 Paris cedex 05 75248 Paris cedex 05 75248 Paris cedex 05
| 005650
| Unité INSERM U830, Institut Curie, 26 rue d'Ulm 75248 Paris cedex 05, France France Unité INSERM U830, Institut Curie, 26 rue d'Ulm 75248 Paris cedex 05 75248 Paris cedex 05 75248 Paris cedex 05
| 005650
| Service de Génétique Oncologique, Institut Curie, 26 rue d'Ulm, Paris 75248, France France Service de Génétique Oncologique, Institut Curie, 26 rue d'Ulm, Paris 75248 75248 ParisÎle-de-France
| 006514
| Unité INSERM U830, Institut Curie, 26 rue d'Ulm, Paris 75248, France France Unité INSERM U830, Institut Curie, 26 rue d'Ulm, Paris 75248 75248 ParisÎle-de-France
| 006514
| Unit of Genetic Epidemiology, International Agency for Research on Cancer, 69008 Lyon, France; France Unit of Genetic Epidemiology, International Agency for Research on Cancer, 69008 Lyon 69008 Lyon LyonAuvergne-Rhône-AlpesRhône-Alpes
| 00C134
| Institut Curie, Department of Tumour Biology, 75248 Paris,France France # see nlm:aff country strict
| 001D24
| Université Paris Descartes, Sorbonne Paris Cité, 75248 Paris,France France # see nlm:aff country strict
| 001D24
| Institut Curie, Department of Tumour Biology, Paris, France; Institut Curie, INSERM U830, 75248 Paris,France France # see nlm:aff country strict
| 001E67
| Université Paris Descartes, Sorbonne Paris Cité, 75270 Paris,France France # see nlm:aff country strict
| 001E67
| Service de Génétique Oncologique,Institut Curie,Paris,France, France # see nlm:aff country strict
| 003283
| INSERM, U830,Paris,France, France # see nlm:aff country strict
| 003283
| Université Paris-Descartes,Paris,France, France # see nlm:aff country strict
| 003283
| Unité INSERM U830,Institut Curie,Paris,France, France # see nlm:aff country strict
| 006568
| Faculté de Médecine,Université Paris Descartes,Paris,France, France # see nlm:aff country strict
| 006568
| Service de Génétique Oncologique, Institut Curie, 26, rue d’Ulm, Paris Cedex 05, France France Service de Génétique Oncologique, Institut Curie, 26, rue d’Ulm, Paris Cedex 05 Paris Cedex 05 Paris Cedex 05
| 001E86
| France Unité de Genetique Oncologique, Institut Curie, Paris Île-de-FranceÎle-de-FranceParis
| 00D940
| Institut Curie, Department of Tumour Biology, Paris, France France Institut Curie, Department of Tumour Biology, Paris Île-de-FranceÎle-de-FranceParis
| 002282
| Institut Curie, Department of Tumour Biology, Paris, France France Institut Curie, Department of Tumour Biology, Paris Île-de-FranceÎle-de-FranceParis
| 005746
| Unité INSERM U830, Institut Curie, Paris, France France Unité INSERM U830, Institut Curie, Paris Île-de-FranceÎle-de-FranceParis
| 005746
| INSERM U509, Service de Génétique Oncologique, Institut Curie, Paris, France France INSERM U509, Service de Génétique Oncologique, Institut Curie, Paris Île-de-FranceÎle-de-FranceParis
| 009A13
| Institut Curie, Department of Tumour Biology, Paris, France France Institut Curie, Department of Tumour Biology, Paris Île-de-FranceÎle-de-FranceParis
| 002C70
| Institut Curie, INSERM U830, Paris, France France Institut Curie, INSERM U830, Paris Île-de-FranceÎle-de-FranceParis
| 002C70
| Service de Génétique Oncologique, Institut Curie, Paris, France France Service de Génétique Oncologique, Institut Curie, Paris Île-de-FranceÎle-de-FranceParis
| 005685
| Unité INSERM U830, Institut Curie, Paris, France France Unité INSERM U830, Institut Curie, Paris Île-de-FranceÎle-de-FranceParis
| 005685
| Institut Curie, Department of Tumour Biology, Paris, France France Institut Curie, Department of Tumour Biology, Paris Île-de-FranceÎle-de-FranceParis
| 003C03
| Institut Curie, INSERM U830, Paris, France France Institut Curie, INSERM U830, Paris Île-de-FranceÎle-de-FranceParis
| 003C03
| Department of Tumour Biology, Institut Curie, Paris, France France Department of Tumour Biology, Institut Curie, Paris Île-de-FranceÎle-de-FranceParis
| 001B52
| Department of Tumour Biology, Institut Curie, Paris, France France Department of Tumour Biology, Institut Curie, Paris Île-de-FranceÎle-de-FranceParis
| 001D22
| Institut Curie, INSERM U830, Paris, France France Institut Curie, INSERM U830, Paris Île-de-FranceÎle-de-FranceParis
| 001D22
| Service de Génétique Oncologique, Institut Curie, Paris, France France Service de Génétique Oncologique, Institut Curie, Paris Île-de-FranceÎle-de-FranceParis
| 006567
| Kelly-Anne Phillips, Sue Anne McLachlan, Prue C. Weideman, and Kate Birch, Peter MacCallum Cancer Centre; Kelly-Anne Phillips, Roger L. Milne, Sue Anne McLachlan, Melissa C. Southey, and John L. Hopper, University of Melbourne; Sue Anne McLachlan, St Vincent's Hospital, Melbourne, Victoria; Michael L. Friedlander, Prince of Wales Hospital, Randwick, New South Wales, Australia; Roger L. Milne, Spanish National Cancer Research Centre; Trinidad Caldes, Hospital Clinico San Carlos, Instituto de Investigación Sanitaria San Carlos, Madrid, Spain; Matti A. Rookus, Netherlands Cancer Institute, Amsterdam; Maartje Hooning and Caroline Seynaeve, Erasmus University Medical Center–Daniel den Hoed Cancer Center, Rotterdam; Rob A.E.M. Tollenaar, Leiden University Medical Centre, Leiden, the Netherlands; Mary B. Daly, Fox Chase Cancer Center, Philadelphia, PA; Antonis C. Antoniou, Susan Peock, Debra Frost, Douglas F. Easton, Steve Ellis, University of Cambridge, Cambridge, United Kingdom; Saundra S. Buys and David Goldgar, Huntsman Cancer Institute at the University of Utah, UT; Nadine Andrieu and Dominique Stoppa-Lyonnet, Institut Curie; Nadine Andrieu, L'Institut National de la Santé et de la Recherche Médicale, U900; Dominique Stoppa-Lyonnet, L'Institut National de la Santé et de la Recherche Médicale, U830; Dominique Stoppa-Lyonnet, Université Paris-Descartes, Paris; Nadine Andrieu, Mines ParisTech, Fontainebleau; Catherine Noguès, Institut Curie, Hôpital René Huguenin, St Cloud; Valérie Bonadona, Université Lyon 1; Valérie Bonadona, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5558; Valérie Bonadona, Centre Léon Bérard, Lyon; Pascal Pujol, Centre Hospitalier Universitaire Arnaud de Villeneuve; Pascal Pujol, L'Institut National de la Santé et de la Recherche Médicale 896, Centre de Recherche en Cancérologie de Marseille Val d'Aurelle, Montpellier, France; Esther M. John, Cancer Prevention Institute of California, Fremont; Esther M. John, Stanford University School of Medicine, Stanford, CA; Mary Beth Terry, Columbia University, New York, NY; Irene L. Andrulis, University of Toronto, Toronto, Ontario; Jacques Simard, Centre Hospitalier Universitaire de Québec and Laval University, Quebec City, Quebec, Canada; Christian F. Singer, Medical University of Vienna, Vienna, Austria; Håkan Olsson, Lund University, Lund, Sweden; Anna Jakubowska, Pomeranian Medical University, Szczecin, Poland; Edith Olah, National Institute of Oncology, Budapest, Hungary; Anne-Marie Gerdes, Rigshospitalet and Copenhagen University, Copenhagen, Denmark; and Lenka Foretova, Masaryk Memorial Cancer Institute, Brno, Czech Republic. République tchèque Kelly-Anne Phillips, Sue Anne McLachlan, Prue C. Weideman, and Kate Birch, Peter MacCallum Cancer Centre; Kelly-Anne Phillips, Roger L. Milne, Sue Anne McLachlan, Melissa C. Southey, and John L. Hopper, University of Melbourne; Sue Anne McLachlan, St Vincent's Hospital, Melbourne, Victoria; Michael L. Friedlander, Prince of Wales Hospital, Randwick, New South Wales, Australia; Roger L. Milne, Spanish National Cancer Research Centre; Trinidad Caldes, Hospital Clinico San Carlos, Instituto de Investigación Sanitaria San Carlos, Madrid, Spain; Matti A. Rookus, Netherlands Cancer Institute, Amsterdam; Maartje Hooning and Caroline Seynaeve, Erasmus University Medical Center–Daniel den Hoed Cancer Center, Rotterdam; Rob A.E.M. Tollenaar, Leiden University Medical Centre, Leiden, the Netherlands; Mary B. Daly, Fox Chase Cancer Center, Philadelphia, PA; Antonis C. Antoniou, Susan Peock, Debra Frost, Douglas F. Easton, Steve Ellis, University of Cambridge, Cambridge, United Kingdom; Saundra S. Buys and David Goldgar, Huntsman Cancer Institute at the University of Utah, UT; Nadine Andrieu and Dominique Stoppa-Lyonnet, Institut Curie; Nadine Andrieu, L'Institut National de la Santé et de la Recherche Médicale, U900; Dominique Stoppa-Lyonnet, L'Institut National de la Santé et de la Recherche Médicale, U830; Dominique Stoppa-Lyonnet, Université Paris-Descartes, Paris; Nadine Andrieu, Mines ParisTech, Fontainebleau; Catherine Noguès, Institut Curie, Hôpital René Huguenin, St Cloud; Valérie Bonadona, Université Lyon 1; Valérie Bonadona, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5558; Valérie Bonadona, Centre Léon Bérard, Lyon; Pascal Pujol, Centre Hospitalier Universitaire Arnaud de Villeneuve; Pascal Pujol, L'Institut National de la Santé et de la Recherche Médicale 896, Centre de Recherche en Cancérologie de Marseille Val d'Aurelle, Montpellier, France; Esther M. John, Cancer Prevention Institute of California, Fremont; Esther M. John, Stanford University School of Medicine, Stanford, CA; Mary Beth Terry, Columbia University, New York, NY; Irene L. Andrulis, University of Toronto, Toronto, Ontario; Jacques Simard, Centre Hospitalier Universitaire de Québec and Laval University, Quebec City, Quebec, Canada; Christian F. Singer, Medical University of Vienna, Vienna, Austria; Håkan Olsson, Lund University, Lund, Sweden; Anna Jakubowska, Pomeranian Medical University, Szczecin, Poland; Edith Olah, National Institute of Oncology, Budapest, Hungary; Anne-Marie Gerdes, Rigshospitalet and Copenhagen University, Copenhagen, Denmark; and Lenka Foretova, Masaryk Memorial Cancer Institute, Brno BrnoMoravie
| 004544
| Department of Tumour Biology, Institut Curie, Paris, France France Department of Tumour Biology, Institut Curie, Paris Île-de-FranceÎle-de-FranceParis
| 003148
| Institut National de la Santé et de la Recherche Médicale (INSERM) U830, Institut Curie, Paris, France France Institut National de la Santé et de la Recherche Médicale (INSERM) U830, Institut Curie, Paris Île-de-FranceÎle-de-FranceParis
| 003148
| Institut Curie, Department of Tumour Biology, Paris, France France Institut Curie, Department of Tumour Biology, Paris Île-de-FranceÎle-de-FranceParis
| 004799
| Service de Genetique Oncologique, Institut Curie, Paris, France France Service de Genetique Oncologique, Institut Curie, Paris Île-de-FranceÎle-de-FranceParis
| 007512
| Institut Curie, INSERM U830, Paris, France France Institut Curie, INSERM U830, Paris Île-de-FranceÎle-de-FranceParis
| 004799
| Institut Curie, Department of Tumour Biology, Paris, France France Institut Curie, Department of Tumour Biology, Paris Île-de-FranceÎle-de-FranceParis
| 004756
| Institut Curie, INSERM U830, Paris, France France Institut Curie, INSERM U830, Paris Île-de-FranceÎle-de-FranceParis
| 004756
| Institut Curie, Department of Tumour Biology, Paris, France France Institut Curie, Department of Tumour Biology, Paris Île-de-FranceÎle-de-FranceParis
| 003B16
| Institut Curie, INSERM U830, Paris, France France Institut Curie, INSERM U830, Paris Île-de-FranceÎle-de-FranceParis
| 003B16
| Institut Curie Hospital Group, Service de Génétique, Paris, France. France Institut Curie Hospital Group, Service de Génétique, Paris Île-de-FranceÎle-de-FranceParis
| 000B44
| Julie Lecarpentier, Karoline B. Kuchenbaecker, Daniel Barrowdale, Joe Dennis, Lesley McGuffog, Goska Leslie, Andrew Lee, Ali Amin Al Olama, Jonathan P. Tyrer, Debra Frost, Steve Ellis, Douglas F. Easton, and Antonis C. Antoniou, University of Cambridge; Karoline B. Kuchenbaecker, The Wellcome Trust Sanger Institute, Hinxton; Marc Tischkowitz, Addenbrooke's Treatment Centre, Addenbrooke's Hospital, Cambridge; D. Gareth Evans, Manchester University, Central Manchester University Hospitals NHS Foundation Trust, Manchester; Alex Henderson, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle upon Tyne; Carole Brewer, Royal Devon and Exeter Hospital, Exeter; Diana Eccles, Southampton University Hospitals NHS Trust, Southampton; Jackie Cook, Sheffield Children's Hospital, Sheffield; Kai-ren Ong, Birmingham Women's Hospital Healthcare NHS Trust, Edgbaston, Birmingham; Lisa Walker, Churchill Hospital, Oxford; Lucy E. Side, Great Ormond Street Hospital for Children NHS Trust; Shirley Hodgson, St George's, University of London; Louise Izatt, Guy's and St Thomas' NHS Foundation Trust; Ros Eeles, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust; Nick Orr, The Institute of Cancer Research, London; Mary E. Porteous, Western General Hospital, Edinburgh; Rosemarie Davidson, South Glasgow University Hospitals, Glasgow; Julian Adlard, Chapel Allerton Hospital, Leeds, United Kingdom; Valentina Silvestri, Piera Rizzolo, Anna Sara Navazio, Virginia Valentini, Veronica Zelli, and Laura Ottini, Sapienza University of Rome, Rome; Angela Toss, Veronica Medici, and Laura Cortesi, University of Modena and Reggio Emilia, Modena; Ines Zanna and Domenico Palli, Cancer Research and Prevention Institute, Florence; Paolo Radice, Siranoush Manoukian, Bernard Peissel, and Jacopo Azzollini, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori (INT); Paolo Peterlongo, Italian Foundation for Cancer Research Institute of Molecular Oncology (IFOM), Milan; Alessandra Viel and Giulia Cini, CRO Aviano, National Cancer Institute, Aviano; Giuseppe Damante, University of Udine, Udine; Stefania Tommasi, Istituto Nazionale Tumori "Giovanni Paolo II", Bari; Elisa Alducci, Silvia Tognazzo, and Marco Montagna, Veneto Institute of Oncology IOV - IRCCS, Padua; Maria A. Caligo, University and University Hospital of Pisa, Pisa, Italy; Penny Soucy and Jacques Simard, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec; Anna Marie Mulligan and Irene L. Andrulis, University of Toronto; Gord Glendon and Irene L. Andrulis, Mount Sinai Hospital, Toronto, Ontario, Canada; Melissa Southey, Ian Campbell, Paul James, and Gillian Mitchell, University of Melbourne, Parkville, Victoria; Amanda B. Spurdle, Helene Holland, and Georgia Chenevix-Trench, QIMR Berghofer Medical Research Institute, Brisbane, Queensland; Ian Campbell, Paul James, and Gillian Mitchell, Peter MacCallum Cancer Centre, East Melbourne, New South Wales, Australia; Esther M. John, Cancer Prevention Institute of California, Fremont; Linda Steele, Yuan Chun Ding, Susan L. Neuhausen, and Jeffrey N. Weitzel, City of Hope, Duarte, CA; Thomas A. Conner and Saundra S. Buys, Huntsman Cancer Institute; David E. Goldgar, University of Utah School of Medicine, Salt Lake City, UT; Andrew K. Godwin, University of Kansas Medical Center, Kansas City; Priyanka Sharma, University of Kansas Medical Center, Westwood, KS; Timothy R. Rebbeck, Harvard TH Chan School of Public Health and Dana Farber Cancer Institute, Boston, MA; Joseph Vijai, Mark Robson, Anne Lincoln, Jacob Musinsky, Pragna Gaddam, and Kenneth Offit, Memorial Sloan Kettering Cancer Center, New York, NY; Jennifer T. Loud and Mark H. Greene, National Cancer Institute, Bethesda, MD; Amanda Ewart Toland and Leigha Senter, The Ohio State University, Columbus, OH; Dezheng Huo, Sarah M. Nielsen, and Olufunmilayo I. Olopade, University of Chicago Medical Center, Chicago, IL; Katherine L. Nathanson and Susan M. Domchek, University of Pennsylvania, Philadelphia; Christa Lorenchick and Rachel C. Jankowitz, University of Pittsburgh Medical Center, Pittsburgh, PA; Fergus J. Couch, Mayo Clinic, Rochester, MN; Ramunas Janavicius, State Research Institute Innovative Medicine Center, Vilnius, Lithuania; Thomas V.O. Hansen, Rigshospitalet, Copenhagen University Hospital, Copenhagen; Anders Bojesen and Henriette Roed Nielsen, Vejle Hospital, Vejle; Anne-Bine Skytte, Lone Sunde, and Uffe Birk Jensen, Aarhus University Hospital, Aarhus; Inge Sokilde Pedersen, Aalborg University Hospital, Aalborg; Lotte Krogh, Torben A. Kruse, and Mads Thomassen, Odense University Hospital, Odense, Denmark; Ana Osorio, National Cancer Research Centre and Spanish Network on Rare Diseases; Miguel de la Hoya, Vanesa Garcia-Barberan, Trinidad Caldes, and Pedro Perez Segura, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid; Judith Balmaña, University Hospital, Vall d'Hebron; Sara Gutiérrez-Enríquez and Orland Diez, Vall d'Hebron Institute of Oncology; Orland Diez, University Hospital Vall d'Hebron; Alex Teulé, Jesús Del Valle, Lidia Feliubadalo, Miquel Angel Pujana, and Conxi Lazaro, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, Barcelona; Angel Izquierdo, Esther Darder, and Joan Brunet, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain; Florentia Fostira, National Centre for Scientific Research "Demokritos," Athens, Greece; Ute Hamann, German Cancer Research Center (DKFZ); Christian Sutter, University Hospital Heidelberg, Heidelberg; Alfons Meindl, Klinikumrechts der Isar, Technical University Munich; Nina Ditsch, Ludwig-Maximilian University, Munich; Andrea Gehrig, University Würzburg, Würzburg; Bernd Dworniczak, University of Münster, Münster; Christoph Engel, University of Leipzig; Dorothea Wand, University Hospital, Leipzig; Dieter Niederacher, University Hospital Düsseldorf, Heinrich-Heine University, Düsseldorf; Doris Steinemann, Hannover Medical School, Hannover; Eric Hahnen, Jan Hauke, Kerstin Rhiem, Barbara Wappenschmidt, and Rita K. Schmutzler, University Hospital Cologne, Cologne; Karin Kast, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden; Norbert Arnold, University Hospital of Schleswig-Holstein, Christian-Albrechts University Kiel, Kiel; Shan Wang-Gohrke, University Hospital Ulm, Ulm, Germany; Christine Lasset, Francesca Damiola, and Laure Barjhoux, Centre Léon Bérard; Sylvie Mazoyer, University of Lyon, Lyon; Dominique Stoppa-Lyonnet and Muriel Belotti, Institut Curie, Paris, France; Mattias Van Heetvelde, Bruce Poppe, Kim De Leeneer, and Kathleen B.M. Claes, Ghent University, Gent, Belgium; Johanna I. Kiiski, Sofia Khan, and Heli Nevanlinna, University of Helsinki; Johanna I. Kiiski, Kristiina Aittomäki, Sofia Khan, and Heli Nevanlinna, Helsinki University Hospital, Helsinki, Finland; Christi J. van Asperen, Leiden University Medical Center, Leiden, the Netherlands; Tibor Vaszko, Miklos Kasler, and Edith Olah, National Institute of Oncology, Budapest, Hungary; Adalgeir Arason, Bjarni A. Agnarsson, Oskar Th. Johannsson, and Rosa B. Barkardottir, Landspitali University Hospital and Biomedical Centre, University of Iceland, Reykjavik, Iceland; Manuel R. Teixeira and Pedro Pinto, Portuguese Oncology Institute; Manuel R. Teixeira, Porto University, Porto, Portugal; Jong Won Lee, Ulsan College of Medicine and Asan Medical Center; Min Hyuk Lee and Jihyoun Lee, Soonchunhyang University and Hospital; Sung-Won Kim and Eunyoung Kang, Daerim St Mary's Hospital; Sue Kyung Park, Seoul National University College of Medicine, Seoul; Zisun Kim, Soonchunhyang University Bucheon Hospital, Bucheon, Korea; Yen Y. Tan, Andreas Berger, and Christian F. Singer, Medical University of Vienna, Vienna, Austria; Sook-Yee Yoon and Soo-Hwang Teo, Sime Darby Medical Centre, Subang Jaya, Malaysia; and Anna von Wachenfeldt, Karolinska University Hospital, Stockholm, Sweden. Suède Julie Lecarpentier, Karoline B. Kuchenbaecker, Daniel Barrowdale, Joe Dennis, Lesley McGuffog, Goska Leslie, Andrew Lee, Ali Amin Al Olama, Jonathan P. Tyrer, Debra Frost, Steve Ellis, Douglas F. Easton, and Antonis C. Antoniou, University of Cambridge; Karoline B. Kuchenbaecker, The Wellcome Trust Sanger Institute, Hinxton; Marc Tischkowitz, Addenbrooke's Treatment Centre, Addenbrooke's Hospital, Cambridge; D. Gareth Evans, Manchester University, Central Manchester University Hospitals NHS Foundation Trust, Manchester; Alex Henderson, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle upon Tyne; Carole Brewer, Royal Devon and Exeter Hospital, Exeter; Diana Eccles, Southampton University Hospitals NHS Trust, Southampton; Jackie Cook, Sheffield Children's Hospital, Sheffield; Kai-ren Ong, Birmingham Women's Hospital Healthcare NHS Trust, Edgbaston, Birmingham; Lisa Walker, Churchill Hospital, Oxford; Lucy E. Side, Great Ormond Street Hospital for Children NHS Trust; Shirley Hodgson, St George's, University of London; Louise Izatt, Guy's and St Thomas' NHS Foundation Trust; Ros Eeles, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust; Nick Orr, The Institute of Cancer Research, London; Mary E. Porteous, Western General Hospital, Edinburgh; Rosemarie Davidson, South Glasgow University Hospitals, Glasgow; Julian Adlard, Chapel Allerton Hospital, Leeds, United Kingdom; Valentina Silvestri, Piera Rizzolo, Anna Sara Navazio, Virginia Valentini, Veronica Zelli, and Laura Ottini, Sapienza University of Rome, Rome; Angela Toss, Veronica Medici, and Laura Cortesi, University of Modena and Reggio Emilia, Modena; Ines Zanna and Domenico Palli, Cancer Research and Prevention Institute, Florence; Paolo Radice, Siranoush Manoukian, Bernard Peissel, and Jacopo Azzollini, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori (INT); Paolo Peterlongo, Italian Foundation for Cancer Research Institute of Molecular Oncology (IFOM), Milan; Alessandra Viel and Giulia Cini, CRO Aviano, National Cancer Institute, Aviano; Giuseppe Damante, University of Udine, Udine; Stefania Tommasi, Istituto Nazionale Tumori "Giovanni Paolo II", Bari; Elisa Alducci, Silvia Tognazzo, and Marco Montagna, Veneto Institute of Oncology IOV - IRCCS, Padua; Maria A. Caligo, University and University Hospital of Pisa, Pisa, Italy; Penny Soucy and Jacques Simard, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec City, Quebec; Anna Marie Mulligan and Irene L. Andrulis, University of Toronto; Gord Glendon and Irene L. Andrulis, Mount Sinai Hospital, Toronto, Ontario, Canada; Melissa Southey, Ian Campbell, Paul James, and Gillian Mitchell, University of Melbourne, Parkville, Victoria; Amanda B. Spurdle, Helene Holland, and Georgia Chenevix-Trench, QIMR Berghofer Medical Research Institute, Brisbane, Queensland; Ian Campbell, Paul James, and Gillian Mitchell, Peter MacCallum Cancer Centre, East Melbourne, New South Wales, Australia; Esther M. John, Cancer Prevention Institute of California, Fremont; Linda Steele, Yuan Chun Ding, Susan L. Neuhausen, and Jeffrey N. Weitzel, City of Hope, Duarte, CA; Thomas A. Conner and Saundra S. Buys, Huntsman Cancer Institute; David E. Goldgar, University of Utah School of Medicine, Salt Lake City, UT; Andrew K. Godwin, University of Kansas Medical Center, Kansas City; Priyanka Sharma, University of Kansas Medical Center, Westwood, KS; Timothy R. Rebbeck, Harvard TH Chan School of Public Health and Dana Farber Cancer Institute, Boston, MA; Joseph Vijai, Mark Robson, Anne Lincoln, Jacob Musinsky, Pragna Gaddam, and Kenneth Offit, Memorial Sloan Kettering Cancer Center, New York, NY; Jennifer T. Loud and Mark H. Greene, National Cancer Institute, Bethesda, MD; Amanda Ewart Toland and Leigha Senter, The Ohio State University, Columbus, OH; Dezheng Huo, Sarah M. Nielsen, and Olufunmilayo I. Olopade, University of Chicago Medical Center, Chicago, IL; Katherine L. Nathanson and Susan M. Domchek, University of Pennsylvania, Philadelphia; Christa Lorenchick and Rachel C. Jankowitz, University of Pittsburgh Medical Center, Pittsburgh, PA; Fergus J. Couch, Mayo Clinic, Rochester, MN; Ramunas Janavicius, State Research Institute Innovative Medicine Center, Vilnius, Lithuania; Thomas V.O. Hansen, Rigshospitalet, Copenhagen University Hospital, Copenhagen; Anders Bojesen and Henriette Roed Nielsen, Vejle Hospital, Vejle; Anne-Bine Skytte, Lone Sunde, and Uffe Birk Jensen, Aarhus University Hospital, Aarhus; Inge Sokilde Pedersen, Aalborg University Hospital, Aalborg; Lotte Krogh, Torben A. Kruse, and Mads Thomassen, Odense University Hospital, Odense, Denmark; Ana Osorio, National Cancer Research Centre and Spanish Network on Rare Diseases; Miguel de la Hoya, Vanesa Garcia-Barberan, Trinidad Caldes, and Pedro Perez Segura, Hospital Clinico San Carlos, El Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid; Judith Balmaña, University Hospital, Vall d'Hebron; Sara Gutiérrez-Enríquez and Orland Diez, Vall d'Hebron Institute of Oncology; Orland Diez, University Hospital Vall d'Hebron; Alex Teulé, Jesús Del Valle, Lidia Feliubadalo, Miquel Angel Pujana, and Conxi Lazaro, Bellvitge Biomedical Research Institute, Catalan Institute of Oncology, Barcelona; Angel Izquierdo, Esther Darder, and Joan Brunet, Institut d'Investigació Biomèdica de Girona, Catalan Institute of Oncology, Girona, Spain; Florentia Fostira, National Centre for Scientific Research "Demokritos," Athens, Greece; Ute Hamann, German Cancer Research Center (DKFZ); Christian Sutter, University Hospital Heidelberg, Heidelberg; Alfons Meindl, Klinikumrechts der Isar, Technical University Munich; Nina Ditsch, Ludwig-Maximilian University, Munich; Andrea Gehrig, University Würzburg, Würzburg; Bernd Dworniczak, University of Münster, Münster; Christoph Engel, University of Leipzig; Dorothea Wand, University Hospital, Leipzig; Dieter Niederacher, University Hospital Düsseldorf, Heinrich-Heine University, Düsseldorf; Doris Steinemann, Hannover Medical School, Hannover; Eric Hahnen, Jan Hauke, Kerstin Rhiem, Barbara Wappenschmidt, and Rita K. Schmutzler, University Hospital Cologne, Cologne; Karin Kast, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden; Norbert Arnold, University Hospital of Schleswig-Holstein, Christian-Albrechts University Kiel, Kiel; Shan Wang-Gohrke, University Hospital Ulm, Ulm, Germany; Christine Lasset, Francesca Damiola, and Laure Barjhoux, Centre Léon Bérard; Sylvie Mazoyer, University of Lyon, Lyon; Dominique Stoppa-Lyonnet and Muriel Belotti, Institut Curie, Paris, France; Mattias Van Heetvelde, Bruce Poppe, Kim De Leeneer, and Kathleen B.M. Claes, Ghent University, Gent, Belgium; Johanna I. Kiiski, Sofia Khan, and Heli Nevanlinna, University of Helsinki; Johanna I. Kiiski, Kristiina Aittomäki, Sofia Khan, and Heli Nevanlinna, Helsinki University Hospital, Helsinki, Finland; Christi J. van Asperen, Leiden University Medical Center, Leiden, the Netherlands; Tibor Vaszko, Miklos Kasler, and Edith Olah, National Institute of Oncology, Budapest, Hungary; Adalgeir Arason, Bjarni A. Agnarsson, Oskar Th. Johannsson, and Rosa B. Barkardottir, Landspitali University Hospital and Biomedical Centre, University of Iceland, Reykjavik, Iceland; Manuel R. Teixeira and Pedro Pinto, Portuguese Oncology Institute; Manuel R. Teixeira, Porto University, Porto, Portugal; Jong Won Lee, Ulsan College of Medicine and Asan Medical Center; Min Hyuk Lee and Jihyoun Lee, Soonchunhyang University and Hospital; Sung-Won Kim and Eunyoung Kang, Daerim St Mary's Hospital; Sue Kyung Park, Seoul National University College of Medicine, Seoul; Zisun Kim, Soonchunhyang University Bucheon Hospital, Bucheon, Korea; Yen Y. Tan, Andreas Berger, and Christian F. Singer, Medical University of Vienna, Vienna, Austria; Sook-Yee Yoon and Soo-Hwang Teo, Sime Darby Medical Centre, Subang Jaya, Malaysia; and Anna von Wachenfeldt, Karolinska University Hospital, Stockholm StockholmSvealand
| 000570
| Service de Génétique Oncologique, Institut Curie, Paris, France. France Service de Génétique Oncologique, Institut Curie, Paris Île-de-FranceÎle-de-FranceParis
| 000A39
| Université Paris-DescartesParisFRA14 aut. France Île-de-FranceÎle-de-FranceParisParis Université Paris-Descartes
| 004D71
| INSERM U509, Service de Génétique Oncologique, Institut Curie, and Université Paris-Descartes, Paris, France France INSERM U509, Service de Génétique Oncologique, Institut Curie, and Université Paris-Descartes, Paris Île-de-FranceÎle-de-FranceParisParis Université Paris-Descartes
| 007535
| Université Paris Descartes, Sorbonne Paris Cité, Paris, France France Université Paris Descartes, Sorbonne Paris Cité, Paris Île-de-FranceÎle-de-FranceParisParis Université Paris-Descartes
| 002282
| INSERM U509, Service de Génétique Oncologique, Institut Curie, Université Paris-Descartes, Paris, France France INSERM U509, Service de Génétique Oncologique, Institut Curie, Université Paris-Descartes, Paris Île-de-FranceÎle-de-FranceParisParis Université Paris-Descartes
| 007558
| INSERM U509, Service de Génétique Oncologique, Institut Curie, Université Paris-Descartes, Paris, France; France INSERM U509, Service de Génétique Oncologique, Institut Curie, Université Paris-Descartes, Paris Île-de-FranceÎle-de-FranceParisParis Université Paris-Descartes
| 005635
| INSERM U509, Service de Génétique Oncologique, Institut Curie, Université Paris-Descartes, Paris, France France INSERM U509, Service de Génétique Oncologique, Institut Curie, Université Paris-Descartes, Paris Île-de-FranceÎle-de-FranceParisParis Université Paris-Descartes
| 006566
| Université Paris Descartes, Faculté de Médecine, Paris, France France Université Paris Descartes, Faculté de Médecine, Paris Île-de-FranceÎle-de-FranceParisParis Université Paris-Descartes
| 005746
| Université Paris Descartes, Sorbonne Paris Cité, France France Université Paris Descartes, Sorbonne Paris Cité Sorbonne Paris Cité Université Paris-Descartes ParisÎle-de-France
| 002C70
| Université Paris Descartes, Faculté de Médecine, Paris, France France Université Paris Descartes, Faculté de Médecine, Paris Île-de-FranceÎle-de-FranceParisParis Université Paris-Descartes
| 005685
| Université Paris Descartes, Sorbonne Paris Cité, France France Université Paris Descartes, Sorbonne Paris Cité Sorbonne Paris Cité Université Paris-Descartes ParisÎle-de-France
| 003C03
| Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, 15 rue de l’école de médecine, 75006 Paris, France France Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, 15 rue de l’école de médecine, 75006 Paris 75006 Paris ParisÎle-de-FranceParis Université Paris-Descartes
| 003172
| Université Paris Descartes, Sorbonne Paris Cité, Paris, France France Université Paris Descartes, Sorbonne Paris Cité, Paris Île-de-FranceÎle-de-FranceParisParis Université Paris-Descartes
| 001B52
| Université Paris Descartes, Sorbonne Paris Cité, Paris, France France Université Paris Descartes, Sorbonne Paris Cité, Paris Île-de-FranceÎle-de-FranceParisParis Université Paris-Descartes
| 001D22
| Université Paris Descartes, Faculté de Médecine, 12, rue de l'Ecole de Médecine 75270 Paris Cedex 06, France France Université Paris Descartes, Faculté de Médecine, 12, rue de l'Ecole de Médecine 75270 Paris Cedex 06 75270 Paris Cedex 06 Université Paris-Descartes ParisÎle-de-France
| 005650
| INSERM U509, Service de Génétique Oncologique, Institut Curie, Université Paris-Descartes, 26 rue d'Ulm, 75248 Paris cedex 05, France France INSERM U509, Service de Génétique Oncologique, Institut Curie, Université Paris-Descartes, 26 rue d'Ulm, 75248 Paris cedex 05 75248 Paris cedex 05 Université Paris-Descartes ParisÎle-de-France
| 007479
| Service de Génétique Oncologique, Institut Curie, Paris, France, Unité INSERM U830, Institut Curie, Paris, France, Université Paris Descartes, Faculté de Médecine, Paris, France France Service de Génétique Oncologique, Institut Curie, Paris, France, Unité INSERM U830, Institut Curie, Paris, France, Université Paris Descartes, Faculté de Médecine, Paris Île-de-FranceÎle-de-FranceParisParis Université Paris-Descartes
| 005689
| Unité INSERM U830, Institut Curie, Paris, France; Université Paris Descartes, Faculté de Médecine, Paris, France France Unité INSERM U830, Institut Curie, Paris, France; Université Paris Descartes, Faculté de Médecine, Paris Île-de-FranceÎle-de-FranceParisParis Université Paris-Descartes
| 006567
| Faculté de Médecine, Université Paris Descartes, 15 rue de l'Ecole de Médecine, Paris 75006, France France Faculté de Médecine, Université Paris Descartes, 15 rue de l'Ecole de Médecine, Paris 75006 75006 ParisÎle-de-FranceParis Université Paris-Descartes
| 006514
| Institut Curie, Service de Génétique, INSERM U830, F-75248, Université Paris Descartes, Paris, France France Institut Curie, Service de Génétique, INSERM U830, F-75248, Université Paris Descartes, Paris Île-de-FranceÎle-de-FranceParisParis Université Paris-Descartes
| 007512
| Université Paris Descartes, Sorbonne Paris Cité, Paris, France France Université Paris Descartes, Sorbonne Paris Cité, Paris Île-de-FranceÎle-de-FranceParisParis Université Paris-Descartes
| 003148
| Université Paris Descartes, Sorbonne Paris Cité, Paris, France France Université Paris Descartes, Sorbonne Paris Cité, Paris Île-de-FranceÎle-de-FranceParisParis Université Paris-Descartes
| 004799
| Université Paris Descartes, Sorbonne Paris Cité, Paris, France France Université Paris Descartes, Sorbonne Paris Cité, Paris Île-de-FranceÎle-de-FranceParisParis Université Paris-Descartes
| 004756
| Université Paris Descartes, Sorbonne Paris Cité, Paris, France France Université Paris Descartes, Sorbonne Paris Cité, Paris Île-de-FranceÎle-de-FranceParisParis Université Paris-Descartes
| 003B16
| Institut Curie, Department of Tumour Biology, Paris, France28Institut Curie, INSERM U830, Paris, France29Université Paris Descartes, Sorbonne Paris Cité, Paris, France. France Institut Curie, Department of Tumour Biology, Paris, France28Institut Curie, INSERM U830, Paris, France29Université Paris Descartes, Sorbonne Paris Cité, Paris Île-de-FranceÎle-de-FranceParisParis Université Paris-Descartes
| 000419
| Institut Curie, Department of Tumour Biology, Paris, France; Institut Curie, INSERM U830, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, France. France Institut Curie, Department of Tumour Biology, Paris, France; Institut Curie, INSERM U830, Paris, France; Université Paris Descartes, Sorbonne Paris Cité Sorbonne Paris Cité Université Paris-Descartes ParisÎle-de-France
| 001A39
| Service de Génétique Oncologique and INSERM U830, Institut Curie, Paris, France - Université Paris Descartes, Sorbonne Paris Cité. Université Paris-Descartes France ParisÎle-de-France
| 000A32
| Université Paris-Descartes France ParisÎle-de-France
| 007643 008419
| Department of Tumour Biology, Institut Curie, 26 rue d’Ulm 75248, Paris, cedex 05 France cedex 05 France
| 003172
| 0000 0001 2188 0914grid.10992.33Université Paris Descartes,Sorbonne Paris Cité, Paris France Paris France
| 003C36
|
| 008E70
|
| 000C68
| Service de Génétique Oncologique
| 006568
| NONE
| 006507 008E08
| Paris France
| 003C36
| cedex 05 France
| 003172
|
|
---|